maternal phenylketonuria
Metabolic · 2020–2020
1decision
1medicine
1carried consumer input
35individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| sapropterin Treatment of hyperphenylalaninaemia (HPA) due to phenylketonuria (PKU) in pregnant women or women actively planning to become pregnant, in combination with a… | Dec 2020 | Recommended with restriction | 35 individuals |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.